Targeting SARS-CoV-2 Variants with Nucleic Acid Therapeutic Nanoparticle Conjugates

• Main Authors: Hanah F. Huber (Author), Majid Jaberi-Douraki (Author), Sarah DeVader (Author), Cesar Aparicio-Lopez (Author), Juliet Nava-Chavez (Author), Xuan Xu (Author), Nuwan Indika Millagaha Gedara (Author), Natasha N. Gaudreault (Author), Robert K. Delong (Author)
• Formato: Libro
• Publicado: MDPI AG, 2021-10-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

The emergence of SARS-CoV-2 variants is cause for concern, because these may become resistant to current vaccines and antiviral drugs in development. Current drugs target viral proteins, resulting in a critical need for RNA-targeted nanomedicines. To address this, a comparative analysis of SARS-CoV-...